Overview

Benign Prostatic Hyperplasia Treatment Market is poised to value over USD 11.8 billion by 2027 end at a CAGR of over 5.9% during the forecast period 2020 to 2027

FutureWise Market Research has instantiated a report that provides an intricate analysis of Benign Prostatic Hyperplasia Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Benign Prostatic Hyperplasia Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Benign Prostatic Hyperplasia Treatment Market:
• Abbott
• Allergan plc
• Astellas Pharma, Inc.
• Asahi Kasei Corporation
• Boehringer Ingelheim GmbH
• GlaxoSmithKline plc
• Pfizer, Inc.
• Sanofi, Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Teleflex Incorporated
• Endo International plc
• Urologix
• LISA Laser
• Olympus Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)


Benign Prostatic Hyperplasia Treatment Market Segmentation:
By Treatment
• Drug Class
  o Alpha-Blockers
  o 5-Alpha-reductase Inhibitors (5-ARIs)
  o Phosphodiesterase-5 Enzyme Inhibitors
  o Others
• Minimally Invasive Surgeries
  o Transurethral Resection of the Prostate (TURP)
  o Transurethral Incision of the Prostate (TUIP)
  o Robotic Surgeries
  o Transurethral Microwave Thermotherapy (TUMT)
  o Prostatic Urethral Lifts
  o Others
• Laser Therapy
• Others

 

By End User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

 

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa


Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants


FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth


Objectives of the Study:
• To provide with an exhaustive analysis on the Benign Prostatic Hyperplasia Treatment Market By Treatment, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions


Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics